Phenotype Phorum 11/6: Roberto Calle & Arun Sanyal, MD
Roberto Calle, Executive Director Pfizer, Industry co-chair of NIMBLE and FNIH MDSC co-chair and Arun Sanyal, MD,Virginia Commonwealth University, Academic Chair of NIMBLE
NIMBLE — Non-Invasive Biomarkers of Metabolic Liver Disease (part of the Biomarkers Consortium housed at the Foundation for the National Institutes of Health)
November 16, 2019: Moving New Diagnostics into the Clinic in the 21st Century
Please join us for this exploration of the reasons traditional biomarkers are insufficient and why we must work across boundaries, old assumptions, and disciplines to reimagine the future in order to prevent, detect, and treat coronary heart disease.
Phenotype Phorum 12/4: Mark Fishman, MD
Mark Fishman, MD, Harvard Stem Cell Institute, former global head of R&D, Novartis